Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on August 8, 2025
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
GlobeNewswire
·
August 8, 2025
Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 superagonist delivery to metastatic tumor sites and reduced immune clearance through engineered CD55 membrane expression; IND …
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of PepGen Inc.(PEPG) Shareholders
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) - September 15, 2025 Deadline to Join – Contact Levi & Korsinsky
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Contact Levi & Korsinsky by September 16, 2025 Deadline to Join Class Action Against Neogen Corporation (NEOG)
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 8, 2025
Daniel Chao, M.D., Ph.D., joins Surrozen as Vice President of Clinical Development Surrozen forms Clinical Advisory Board comprised of leading retinal specialists Data Presentations at Association for Research in Vision and Ophthalmology Annual Meeting and …
Monroe Capital Corporation Schedules Second Quarter 2025 Earnings Release
GlobeNewswire
·
August 8, 2025
CHICAGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that it will report its second quarter ended June 30, 2025 financial results on Monday, August 11, 2025, after the close of the financial …
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
GlobeNewswire
·
August 8, 2025
– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant – – Vepdegestrant is the first PROteolysis TArgeting Chimera ( …
Femasys Announces Second Quarter Financial Results for 2025
GlobeNewswire
·
August 8, 2025
-- Continued Progress on Regulatory Approvals and Global Commercialization of Fertility Portfolio -- ATLANTA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth …
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
August 8, 2025
FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatment Significant regulatory and pipeline advancements achieved …
Commerce to Present at Upcoming Investor Conference
GlobeNewswire
·
August 8, 2025
AUSTIN, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver …
Capital Clean Energy Carriers Corp. Announces Annual Meeting of Shareholders
GlobeNewswire
·
August 8, 2025
ATHENS, Greece, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Capital Clean Energy Carriers Corp. (NASDAQ: CCEC) (the “Corporation” or “CCEC”) has called an annual meeting of shareholders to be held at the Corporation’s headquarters in Greece …
Phunware Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 8, 2025
Delivers Strong First Half with Key Product Milestones and Customer Momentum Strong Liquidity Powering New Technology Improvements, AI Integration and Corporate Initiatives AUSTIN, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. (“Phunware” or the …
Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Hyperion Defi, Inc. (NASDAQ: HYPD), the first U.S. public company to build a strategic treasury around the HYPE token and a pioneer in integrating decentralized finance with traditional corporate treasury …
Flywire Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 23, 2025 to Discuss Your Rights – FLYW
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Shareholders that lost money on Sarepta Therapeutics, Inc.(SRPT) should contact Levi & Korsinsky about pending Class Action - SRPT
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
GlobeNewswire
·
August 8, 2025
TORONTO and HAIFA, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced that an independent study showed that exosomes produced by NurExone outperformed a …
Levi & Korsinsky Notifies Petco Health and Wellness Company, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – WOOF
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi …
Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
GlobeNewswire
·
August 8, 2025
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, will release its financial results for the quarter ended …
SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 8, 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …